Completed OBSERVATIONAL NCT03907553

Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly

Sponsor: Istituto Clinico Humanitas

Interventions targeted genome sequencing

Updated 4 times since 2019 Last updated: Apr 19, 2019 Started: Jul 31, 2003 Primary completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03907553, this observational or N/A phase trial focuses on Anemia and Clonal Hematopoiesis and remains completed. Sponsored by Istituto Clinico Humanitas, it has been updated 4 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
May 2019 — Jan 2021 [monthly]

Completed

First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istituto Clinico Humanitas
Istituto Di Ricerche Farmacologiche Mario Negri

Data source: Istituto Clinico Humanitas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rozzano, Italy